← Back to Search

Mobile Health App for High Blood Pressure

N/A
Recruiting
Led By David G. Beiser, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18 to 65 years old
Prior hypertension (HTN) diagnosis
Must not have
Hypertension is managed by a specialist (specialist prescribes the anti-hypertensive therapies)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights
No Placebo-Only Group

Summary

This trial tests an app to help manage high blood pressure in African American adults, to see if it works better than usual care.

Who is the study for?
This trial is for African American adults aged 18-65 with high blood pressure (SBP ≥ 160 mmHg). Participants must have access to an iPhone, Wi-Fi or data plan, and be able to use the USeeBP app and a wireless blood pressure cuff. They should not be homeless, recently hospitalized for psychiatric reasons, pregnant, prisoners, opioid-dependent or have certain severe medical conditions.
What is being tested?
The study tests a mobile health application called USeeBP as part of the UChicago Medicine Remote-Patient Monitoring Hypertension Management Program. It aims to see if this app can help improve blood pressure control in African Americans with unmanaged hypertension.
What are the potential side effects?
Since this trial involves using a mobile health application rather than medication, traditional side effects are not expected. However, participants may experience issues related to technology use such as privacy concerns or stress from monitoring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with high blood pressure.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My high blood pressure is managed by a specialist.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in home BP
Secondary study objectives
Change in BP control rate
Change in medication adherence
Number of EPIC myChart patient-provider messages and replies
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: USeeBPExperimental Treatment1 Intervention
Participants will be asked to use the USeeBP mHealth app alongside participating in UCM-RPM program as part of their routine care.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
840,106 Total Patients Enrolled
David G. Beiser, MDPrincipal InvestigatorUniversity of Chicago
~12 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top